Drug or device? Canada demystifies classification
15 March 2013
- Predicting the future of EU genetic testing regulation - opportunities and pitfalls
- Report calls for more US FDA scrutiny on increase in device submission withdrawals
- ANALYSIS: are EU rules on SUD reprocessing more muddled than ever?
- INTERVIEW: IVDs in focus as UK builds a platform for growth and test adoption
Other Informa News